VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

TCT 2021 | Outcomes after reduced-intensity conditioning based HCT for dyskeratosis congenita

Dyskeratosis congenita is a multisystem disorder caused by impaired telomere maintenance. In this interview, Akshay Sharma, MBBS, of St. Jude Children’s Research Hospital, Memphis, TN, outlines the outcomes of patients with dyskeratosis congenita treated with reduced-intensity conditioning based hematopoietic cell transplantation (HCT). This interview took place during the Transplantation & Cellular Therapy (TCT) 2021 Meetings.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter